The Antimalarial Potential of 4-Quinolinecarbinolamines May Be Limited due to Neurotoxicity and Cross-Resistance in Mefloquine-Resistant Plasmodium falciparum Strains

The clinical potential of mefloquine has been compromised by reports of adverse neurological effects. A series of 4-quinolinecarbinolamines were compared in terms of neurotoxicity and antimalarial activity in an attempt to identify replacement drugs. Neurotoxicity (MTT [thiazolyl blue reduction] ass...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Antimicrob Agents Chemother
Główni autorzy: Dow, Geoffrey S., Koenig, Michael L., Wolf, Lesley, Gerena, Lucia, Lopez-Sanchez, Miriam, Hudson, Thomas H., Bhattacharjee, Apurba K.
Format: Artigo
Język:Inglês
Wydane: American Society for Microbiology (ASM) 2004
Hasła przedmiotowe:
Mechanisms of Action: Physiological Effects
Dostęp online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC434181/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15215119/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.7.2624-2632.2004
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy